Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Labeling Reform Will Trim Adverse Event Section, Temple Says

Executive Summary

FDA's package insert reform initiatives include a thinning out of the adverse event section, CDER Office of Medical Policy Director Robert Temple, MD, told a public workshop on risk management April 10

You may also be interested in...



Labeling And Liability: FDA Wary Of “Over-Warning,” “Piling On” By Lawyers

Trial lawyers should work with FDA to focus product liability actions on cases where manufacturers appear to be withholding information, Commissioner McClellan suggested during the National Community Pharmacists Association legislative conference May 19 in Washington, D.C

Labeling And Liability: FDA Wary Of “Over-Warning,” “Piling On” By Lawyers

Trial lawyers should work with FDA to focus product liability actions on cases where manufacturers appear to be withholding information, Commissioner McClellan suggested during the National Community Pharmacists Association legislative conference May 19 in Washington, D.C

FDA Strategic Plan: Milestones Will Be Unveiled In June

FDA plans to outline milestones for implementing a strategic action plan in a document slated for release by early June

Related Content

UsernamePublicRestriction

Register

PS041647

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel